1. Medtech Insight
  2. >>Leadership
  3. >>Interviews

Dexcom’s Jake Leach And Adrian Gut Discuss Strategy For CGM Growth, Reimbursement, AI Integration And Policy Challenges

Dexcom Executives Tackle Key Issues Shaping The Future Of CGM Technology Worldwide

 
• By Shubham Singh

In an interview with Medtech Insight, Dexcom’s COO Jake Leach and Adrian Gut, senior director international access, discuss the company’s global expansion, the role of AI in diabetes management, the challenges of securing reimbursement, and how regulators are influencing the future of CGM technology.

In this in-depth conversation, they discuss the challenges of expanding Dexcom’s global footprint, the company’s reimbursement strategy, and the evolving role of regulators in fostering innovation.

More from Interviews

More from Medtech Insight

Roar Of Eargo-hearX Merger Echoes Through US OTC Hearing Aid Market

 
• By Malcolm Spicer

The firms recently announced they will operate as combined company LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands. Eargo majority owner Patient Square Capital added $100m to its investment.

Birmingham City University Develops New Defense Mechanism Against Cyberattacks On AI Systems

 
• By Natasha Barrow

AI systems used in healthcare are vulnerable to adversarial cyberattacks, which are a growing concern, said Atif Azad, a professor of AI at Birmingham City University. Azad’s research group has developed a method that trains AI to become more resilient to cyber threats through the use of random image adjustments.

Opportunity For Medtech To Contribute To EU Cybersecurity Recommendations

 
• By Amanda Maxwell

The deadline for comments is 30 June 2025